Abstract
Iotrolan is a non-ionic hexa-iodinated dimeric contrast agent suitable for Ct enhancement, angiography, urography and the opacofocation of body cavities. It is more hydrophilic than any other X-ray contrast agent and is sweet to tast. Iotrolan 280 is isotnoc to blood and its pharmacokinetics are almost identical to other urographic contrast agents. The experiments reported in this review show very little protein binding, enzyme inhibition or injury to membranes of human erythrocytes, rat mast cells or cultured human enfothelial cells. Osmotically induced side effects, such as vascular pain, endothelial damage, disturbance of the blood-brain barner, vaso-contruction and hemodilution are greatly reduced or absent. In various studies in rats and dogs, the mechanical and electrical function of the heart and myocardial perfusion remained almost unaffected. In rats, renal tolerance of iotrolan was superior to that of a non-ionic monomer when the contrast agents were-infused into the renal arteries. The renal tolerance after intravenous injection depends on the anomal species and experimental conditions, with favorable results in most cases. The intravenous, LD 50 is very high and seems to be restricted more by physical overload of the animals tahn b osmotic or chemotoxic effects. Due to reduced osmotic diultion the contrast efficacy is slightly better than higher osmolality agents.
Similar content being viewed by others
References
Sovak M, Ranganathan R, Speck U (1982) Nonionic dimer: development and initial testing of an intrathecal contrast agent. Radiology 142: 115–118
Krause W, Miklautz H, Kollenkirchen U, Heimann G (1994) Physicochemical parameters of X-ray contrast media. Invest Radiol 29: 72–80
Mützel W, Press WR, Weinmann HJ (1989) Physicochemical properties and general pharmacology of the nonionic dimer iotrolan. In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart, pp 28–32
Evill CA, Wilcox J, Hassam RM, Benness GT, Arozoo E (1988) Examination of the nephrographic potential of iotrol by computed tomography. Invest Radiol 23: 216–220
Nauert C, Mützel W (1989) Experimental urography in dogs: diagnostic quality and pharmacokinetic behaviour of iotrolan in comparison to nonionic and ionic, monomeric contrast media. In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart, pp 82–87
Scholz P, Weinmann HJ, Mützel W, Staks T (1989) Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers. In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart, pp 211–214
Weimann HJ, Scholz P, Mützel W (1989) Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals. In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart, pp 206–210
Dawson P, Howell M (1986) The non-ionic dimers: a new class of contrast agents. Br J Radiol 59: 987–991
Bien S, Schumacher M, Detmar M (1987) Nucleolysis and diskography — an experimental study on interaction of chymopapain and contrast medium. Neuroradiology 29: 483–487
Mutzel W, Siefert HM, Speck U (1980) Biochemical-pharmacologic properties of iohexol. Acta Radiologica 362 (suppl): 111–115
Speck U, Mützel W, Mannesmann G, Pfeiffer H, Siefert HM (1980) Pharmacology of nonionic dimers. Invest Radiol 5: 317–322
Morgan DML, Bettmann MA (1989) Effects of X-ray contrast media and radiation on human vascular endothelial cells in vitro. Cardiovasc Intervent Radiol 12: 154–160
Sovak M, Ranganathan R, Kerber CW, Bickford R, Alksne JF (1983) Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis. AJNR 4: 319–322
Speck U, Press WR, Mützel W (1988) Osmolality-related effects of injections into the central nervous system. Invest Radiol 23 (suppl 1):S114-S117
Speck U, Siefert HM, Klink G (1980) Contrast media and pain in peripheral arteriography. Invest Radiol 15 (suppl):S335-S339
Thiesen B, Mützel W (1990) Effects of angiographic contrast media on venous endothelium of rabbits. Invest Radiol 25: 121–126
Wilcox J, Evill CA, Sage MR (1986) Effects of intracarotid ionic and non-ionic contrast material on the blood-brain barrier in a rabbit model. Neuroradiology 28: 271–274
Wilson AJ, Evill CA, Sage MR (1991) Effects of nonionic contrast media on the blood-brain barrier: osmolality versus chemotoxicity. Invest Radiol 26: 1091–1094
Gomi N (1992) Vasoconstriction by angiographic contrast media in isolated canine arteries. Br J Radiol 65: 961–967
Fleetwood G, Bettmann MA, Gordon JL (1990) The effects of radiographic contrast media on myocardial contractility and coronary resistance: osmolality, ionic concentration, and viscosity. Invest Radiol 25: 254–260
Hayakawa K, Yamashita K (1988) Contrast media-induced ventricular fibrillation. Invest Radiol 23 (suppl 1):S144-S146
Lanzer P, Dean PB, Lipton MJ, Sievers R, Botvinick E, Higgins CB (1985) Effects of intravenous administration of a new nonionic dimeric contrast medium on the coronary circulation: comparison with monomeric ionic and nonionic media. Invest Radiol 20: 746–750
Benness G, Evill C, Wilcox J, Hassam R, Arozoo E (1989) Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs: In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart, pp 88–90
Speck U, Press WR, Mützel W (1983) Albuminuria following renal arteriography with various ionic and nonionic contrast agents in the rat. In: Taenzer V, Zeitler E (eds) Urography, angiography and computerized tomography. Thieme, Stuttgart, pp 25–29
Oldroyd S, Haylor J, Morcos SK, El Nahas AM (1994) Reduced depression of renal function by iotrolan in the isolated rat kidney. Eur J Radiol 18: 64–69
Tervahartiala P, Kivisaari L, Kivisaari R, Virtanen I (1992) Contrast media-induced renal morphologic lesions during experimental hemorrhagic necrotizing pancreatitis. Invest Radiol 12: 1064–1068
Ueda J, Nygren A, Hansell P, Ulfendahl HR (1993) Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 34: 83–87
Ueda J, Nygren A, Hansell P, Erikson U (1992) Influence of contrast media on single nephron glomerular filtration rate in rat kidney. Acta Radiol 33: 596–599
Weinmann HJ, Mützel W (1983) Experimental studies on the early distribution of contrast media. In: Felix R, Frommhold W, Lissner J, Maeney TF, Niendorf HP, Zeitler E (eds) Contrast media in digital radiography. Excerpta Medica, Tokyo, pp 94–103
Nauert C, Langer M, Mützel W (1989) Hemorrheologic effects of iotrolan after intra-arterial injection in rabbits: comparison with other types of contrast media: In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart, pp 40–45
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Speck, U. Preclinical findings with iotrolan: a short review. Eur. Radiol. 5 (Suppl 2), S8–S13 (1995). https://doi.org/10.1007/BF02343254
Issue Date:
DOI: https://doi.org/10.1007/BF02343254